Pharmala Biotech Holdings Investor Relations Material
Latest events
Q1 2025
Pharmala Biotech Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pharmala Biotech Holdings Inc
Access all reports
Pharmala Biotech Holdings Inc is a biotechnology company focused on the research, development, and manufacturing of medical-grade psychedelic compounds. The company specializes in the production of MDMA and related substances for use in scientific research and potential therapeutic applications. Its activities include active pharmaceutical ingredient (API) synthesis, regulatory compliance, and supply to clinical trial sponsors and academic institutions. The company is headquartered in Vancouver, Canada, and its shares are listed on the CSE.
Latest articles
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
Ticker symbol
MDMA
Country
🇨🇦 Canada